133 related articles for article (PubMed ID: 15470598)
1. Federation of the European Pharmacological Societies-fourth annual meeting. Part II. 14-17 July 2004, Porto. Portugal.
Urch C
IDrugs; 2004 Sep; 7(9):833-5. PubMed ID: 15470598
[TBL] [Abstract][Full Text] [Related]
2. Federation of European Pharmacological Societies-fourth annual meeting. Part I. 14-17 July 2004, Porto, Portugal.
Pivac N; Muck-Seler D
IDrugs; 2004 Sep; 7(9):829-32. PubMed ID: 15470597
[No Abstract] [Full Text] [Related]
3. Abstracts of the 4th Congress of the Federation of the European Pharmacological Societies (EPHAR) and of the Serotonin Satellite Meeting. July 2004, Porto, Portugal.
Fundam Clin Pharmacol; 2004 Jul; 18 Suppl 1():5-164. PubMed ID: 15209713
[No Abstract] [Full Text] [Related]
4. EPHAR 99--Second European Congress of Pharmacology. 3-7 July 1999, Budapest, Hungary.
Pivac N; Muck-Seler D
IDrugs; 1999 Sep; 2(9):845-7. PubMed ID: 16121291
[TBL] [Abstract][Full Text] [Related]
5. Systems medicine, personalized health and therapy.
Siest G; Auffray C; Taniguchi N; Ingelman-Sundberg M; Murray H; Visvikis-Siest S; Ansari M; Marc J; Jacobs P; Meyer U; Van Schaik RH; Müller MM; Wevers RA; Simmaco M; Kussmann M; Manolopoulos VG; Alizadeh BZ; Beastall G; Németh G
Pharmacogenomics; 2015; 16(14):1527-39. PubMed ID: 26401575
[TBL] [Abstract][Full Text] [Related]
6. Trends in safety pharmacology: posters presented at the annual meetings of the Safety Pharmacology Society 2001-2010.
Redfern WS; Valentin JP
J Pharmacol Toxicol Methods; 2011; 64(1):102-10. PubMed ID: 21635957
[TBL] [Abstract][Full Text] [Related]
7. Current Challenges and Potential Opportunities for the Pharmaceutical Sciences to Make Global Impact: An FIP Perspective.
Tucker G; DeSilva B; Dressman J; Ito M; Kumamoto T; Mager D; Mahler HC; Maitland-van der Zee AH; Pauletti GM; Sasaki H; Shah V; Tang D; Ward M
J Pharm Sci; 2016 Sep; 105(9):2489-2497. PubMed ID: 26886325
[TBL] [Abstract][Full Text] [Related]
8. [Neuro-immunomodulation in pharmacology. Second course of the Federation of the European Pharmacological Societies, Paris, 5-7 February 1992].
Schnuch A
Hautarzt; 1992 Nov; 43(11):739-42. PubMed ID: 1468938
[No Abstract] [Full Text] [Related]
9. Conference scene: pharmacogenomics: from cell to clinic (part 2).
Siest G; Medeiros R; Melichar B; Stathopoulou M; Van Schaik RH; Cacabelos R; Abt PM; Monteiro C; Gurwitz D; Queiroz J; Mota-Filipe H; Ndiaye NC; Visvikis-Siest S
Pharmacogenomics; 2014 Apr; 15(6):739-44. PubMed ID: 24897282
[TBL] [Abstract][Full Text] [Related]
10. Abstracts of the EPHAR (Federation of the European Pharmacological Societies) 2008 Congress. Manchester, United Kingdom. July 13-17, 2008.
Fundam Clin Pharmacol; 2008 Aug; 22 Suppl 2():1-131. PubMed ID: 18578695
[No Abstract] [Full Text] [Related]
11. Federation of European Biochemical Societies, 14th Meeting, Edinburgh, Scotland, 1981. Abstracts of symposia and posters.
Biochem Soc Trans; 1981 Apr; 9(2):1P-358P. PubMed ID: 7215691
[No Abstract] [Full Text] [Related]
12. Review: 5-HT1, 5-HT2, 5-HT3 and 5-HT7 Receptors and their Role in the Modulation of Pain Response in the Central Nervous System.
Cortes-Altamirano JL; Olmos-Hernandez A; Jaime HB; Carrillo-Mora P; Bandala C; Reyes-Long S; Alfaro-Rodríguez A
Curr Neuropharmacol; 2018 Jan; 16(2):210-221. PubMed ID: 28901281
[TBL] [Abstract][Full Text] [Related]
13. Selective 5-HT6 receptor ligands: progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders.
Heal DJ; Smith SL; Fisas A; Codony X; Buschmann H
Pharmacol Ther; 2008 Feb; 117(2):207-31. PubMed ID: 18068807
[TBL] [Abstract][Full Text] [Related]
14. The endogenous cannabinoid system and its role in nociceptive behavior.
Cravatt BF; Lichtman AH
J Neurobiol; 2004 Oct; 61(1):149-60. PubMed ID: 15362158
[TBL] [Abstract][Full Text] [Related]
15. SUS/AAS abstracts: what is the scientific impact?
Housri N; Cheung MC; Gutierrez JC; Zimmers TA; Koniaris LG
Surgery; 2008 Aug; 144(2):322-31. PubMed ID: 18656642
[TBL] [Abstract][Full Text] [Related]
16. Proceedings of the symposium on safety pharmacology, presented during the 3rd EPHAR meeting, Lyon, 6-9 July 2001. European Pharmacological Societies.
Fundam Clin Pharmacol; 2002 Apr; 16(2):73-156. PubMed ID: 12102033
[No Abstract] [Full Text] [Related]
17. Welcome to the European Society for Artificial Organs-International Federation for Artificial Organs joint congress in Porto, Portugal.
Reis RL; Vienken J; Schima H; Wagner W; Tominaga R
Artif Organs; 2011 Sep; 35(9):838-9. PubMed ID: 21906091
[No Abstract] [Full Text] [Related]
18. Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling.
Hirst WD; Abrahamsen B; Blaney FE; Calver AR; Aloj L; Price GW; Medhurst AD
Mol Pharmacol; 2003 Dec; 64(6):1295-308. PubMed ID: 14645659
[TBL] [Abstract][Full Text] [Related]
19. Veterinary pathology in Europe in the light of the congresses of the European Society of Veterinary Pathology in the last decade.
Gesek M; Szarek J; Babińska I; Wojtacka J; Sobczak-Filipiak M; Felsmann MZ
Pol J Vet Sci; 2008; 11(2):193-7. PubMed ID: 18683550
[TBL] [Abstract][Full Text] [Related]
20. Research on nicotine and tobacco: a decade of progress.
Drobes D; Klein LC
Nicotine Tob Res; 2004 Aug; 6(4):695-741. PubMed ID: 15370167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
